Brandon S. Bentzley

机构：Magnus Chemicals (Canada), Collaborative Drug Discovery (United States), Bay Medical Center, Stanford University · ORCID：0000-0001-6014-4514

发表论文 75 篇 · 总被引 4289 次 · h-index 23

代表论文

Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial (2021 · American Journal of Psychiatry · 被引 797)
Opponent control of reinforcement by striatal dopamine and serotonin (2024 · Nature · 被引 49)
Striatal dopamine integrates cost, benefit, and motivation (2023 · Neuron · 被引 46)
Fast depressive symptoms improvement in bipolar I disorder after Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT): A two-site feasibility and safety open-label trial (2024 · Journal of Affective Disorders · 被引 20)
Stanford neuromodulation therapy for treatment‐resistant depression: a randomized controlled trial confirming efficacy, and an EEG study providing insight into mechanism of action and a potentially predictive biomarker of efficacy (2026 · World Psychiatry · 被引 13)
Durability of clinical benefit with Stanford Neuromodulation Therapy (SNT) in treatment-resistant depression (2025 · Brain stimulation · 被引 13)